Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: yosi s who wrote (316)	1/3/1999 10:18:00 PM
From: BRAVEHEART	Read Replies (2) of 1386

Hi yosi s, Could you describe to me what sort of conversion process is PARS under? How much and at what rate? I also noticed there is little cash. How much in revenues does PARS anticipate over the next year? How does one arrive at conservative yet realistic figures. Is it likely for PARS to draw down more with its convertible financing? What sort of partnering or collaborations are anticipated over the next year? LONE WOLF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next